Effects of Lansoprazole on Bone Turnover Markers

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

December 2, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

July 1, 2021

Conditions
Bone Turnover Rate DisorderCalcium Metabolism Disorders
Interventions
DIAGNOSTIC_TEST

Blood and urine specimens

Blood and urine samples will be taken at baseline and at the end of the second month. For this purpose, 5 ml of blood samples will be taken to plain blood tubes for evaluation of calcium, magnesium, alkaline phosphatase, parathormone, 25-OH vitamin D and osteocalcin quantities. And 3 ml of urine for calcium, creatinine, deoxypyridinoline, C-terminal telopeptides type-1 collagen and N- terminal telopeptides type-1 collagen.

Trial Locations (1)

25240

Ataturk University Hospital, Erzurum

All Listed Sponsors
lead

Ataturk University

OTHER

NCT04814316 - Effects of Lansoprazole on Bone Turnover Markers | Biotech Hunter | Biotech Hunter